PRMT1 and neuroblastoma: MYCN-amplified tumors exhibited high levels of PRMT1 and PRMT5; knockdown of either PRMT1 or PRMT5 led to downregulation of MYCN and suppression of cell growth, suggesting a dependence of MYCN-amplified neuroblastoma on PRMTs3,4.